Steviol Rebaudiosides bind to four different sites of the human sweet taste receptor (T1R2/T1R3) complex explaining confusing experiments

Judith Su,Shuang Hao,Soo-Kyung Kim,Brian Guthrie,Babar Murtaza,Naim Khan,Pouyan Khakbaz,Jan Kubicek,Sergej Balanda,William Goddard

DOI: https://doi.org/10.26434/chemrxiv-2024-xklj4

2024-01-10

Abstract:Sucrose provide sweetness and energy when it binds to both the Venus fly trap domains (VFD) of heterodimeric sweet taste receptor (T1R2/T1R3),1 while non-caloric sweeteners (Sucralose, Aspartame, Neotame, Saccharin, Acesulfame-K (Ace-K), Suosan, SC-45647, Fructose, and D-Tryptophan) bind only at the VFD of T1R2 (VFD2) to provide high-intensity sweetness.2 Here, we address the binding mechanism of various steviol glycosides (Rebaudioside B (RebB), RebM, RebD, Rubusoside (Rubu), RebC), artificial sweeteners (Neohesperidin dihydrochalcone (NHDC), acesulfame K, S-819, Amiloride, and Perillartine), and negative allosteric modulator (Lactisole) at four distinct binding sites, VFD2, VFD3, transmembrane domain 2 (TMD2) and TMD3 by performing binding experiments and computational docking studies. Our docking results find multiple binding sites for the tested ligands including the radio labelled ligands, which provides an explanation of the mixed data of the radio-ligand binding experiments. We predict different preferred binding sites depending on ligand modifications of steviol glycosides. Thus, Rubu binds best at VFD3, while RebB binds best at TMD3, while the others prefer VFD2. We also observed G protein-coupled receptor (GPCR) allostery using the label free Frequency Locking Optical Whispering Evanescent Resonator (FLOWER) method. We show experimentally that the C20 carboxy terminus of the Gα protein can bind to the intracellular region of either TMD2 or TMD3, which can alter GPCR affinity to the high-affinity state for steviol glycosides. These studies provide a mechanistic understanding of the structure and function of this heterodimeric sweet taste receptor that can guide rational structure-based design of novel non-caloric sweeteners aimed at enabling lower sugar usage levels while retaining the sweet taste. This may provide the basis for novel therapeutic applications for treatment of obesity and related metabolic dysfunctions such as diabetes.

Chemistry

What problem does this paper attempt to address?

The paper primarily explores the mechanisms by which various rebaudiosides and other artificial sweeteners bind to human sweet taste receptors (T1R2/T1R3 complex) and attempts to address the following key issues:

1. **Multi-site Binding Issue**: The study found that rebaudiosides and other sweeteners can bind to four different sites on the sweet taste receptor (VFD2, VFD3, TMD2, and TMD3). This helps explain previously confusing data from radiolabeled ligand binding experiments.

2. **Structure-Function Relationship**: Through a combination of binding experiments and computational docking studies, the paper predicts the preferences of different rebaudioside modifications for these binding sites. For example, Rubusoside tends to bind to VFD3, while Rebaudioside B prefers to bind to TMD3.

3. **GPCR Regulation Mechanism**: The study also observed the allosteric effects of G protein-coupled receptors (GPCRs) and used a label-free optical resonance method (FLOWER) to demonstrate that the carboxyl terminus of the Gα protein can bind to the intracellular regions of TMD2 or TMD3, thereby altering the affinity state of the GPCR for rebaudiosides.

4. **Designing Novel Non-caloric Sweeteners**: Based on these findings, the paper aims to provide guidance for the rational design of novel non-caloric sweeteners that can reduce sugar intake while maintaining sweetness. This has potential applications in treating obesity and related metabolic disorders such as diabetes.

In summary, the main issues the paper attempts to address are understanding how rebaudiosides and other sweeteners bind to human sweet taste receptors and how this binding affects the functional state of the receptors. Additionally, it aims to explore the implications of these findings for developing more effective non-caloric sweeteners.